Catalyst Event
AbbVie Inc (ABBV) · Other
From KEDI U.S. Dividend100 90% Participation + Daily Options Premium Index (KUSDV100P)
3/18/2026, 12:00:00 AM
Appeals court ruling on whistleblower lawsuit regarding 340B program overcharging allegations scheduled for March 18, 2026; moderate impact expected from potential legal liabilities, scheduled.
Korean Translation
2026년 3월 18일 340B 프로그램 과다 청구 의혹 관련 내부고발자 소송 항소심 판결 예정; 법적 책임에 따른 중간 수준의 영향이 예상됨.
Related Recent Events
Devon Energy Corp (DVN) · Earnings Release
Market reaction is estimated to be significant as the first report post-merger; Q1 2026 earnings release is scheduled.
5/5/2026, 12:00:00 AM
Conocophillips (COP) · Earnings Release
First-quarter 2026 financial and operating results are scheduled to be released before the market opens on April 30, 2026. Medium importance estimated as earnings reports typically drive significant price movement, scheduled.
4/30/2026, 12:00:00 AM
Halliburton Co (HAL) · Earnings Release
First quarter 2026 earnings release and conference call scheduled. This scheduling announcement is estimated to have a price impact of 1% or more, scheduled.
4/28/2026, 12:00:00 AM
Chevron Corp (CVX) · Earnings Release
Chevron is scheduled to report its Q1 2026 earnings on April 24, 2026; analysts forecast an EPS of $1.72, scheduled.
4/24/2026, 12:00:00 AM
Comcast Corp (CMCSA) · Earnings Release
First quarter 2026 earnings release and conference call on April 23, 2026, with importance estimated as Low as it is a routine earnings announcement, scheduled.
4/23/2026, 12:00:00 AM
CME Group Inc (CME) · Earnings Release
CME Group is scheduled to announce its earnings for the first quarter of 2026 before the market opens on April 22, 2026; low importance is estimated as the announcement is expected to cause at least a 1% price impact, scheduled.
4/22/2026, 12:00:00 AM